A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis
Clinical trial NCT05334472 · COMPLETED
Trial details
- NCT number
- NCT05334472
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-24
- Primary completion
- 2023-02-15
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.